Pharmacists say the Trump administration’s proposed rule to allow Canadian drug imports poses broad drug safety concerns for Americans due to lack of supply chain oversight and labeling issues. Pharmacists also say the proposed rule would not lower drug costs for patients. Canadian drug importation is one of the Trump administration’s two major pushes to lower drug costs -- the other is to tie Medicare Part B drug reimbursement to international prices. Vermont, Colorado, Florida and Maine have taken steps...